# Capsaicin in Digital Osteoarthritis Versus Control

> **NCT06444919** · PHASE4 · RECRUITING · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 120 (estimated)

## Conditions studied

- Osteoarthritis Hand
- Neuropathic Pain

## Interventions

- **DRUG:** Capsaicin 179 Mg Cutaneous Patch
- **DRUG:** Capsaicine low dose 0.04 %

## Key facts

- **NCT ID:** NCT06444919
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-07
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06444919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06444919, "Capsaicin in Digital Osteoarthritis Versus Control". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06444919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*